Endoscopic retrograde cholangiopancreatography - A review of the literature from the last two years;Endoskopowa cholangiopankreatografia wsteczna - Przeglad piśmiennictwa z ostatnich dwóch lat

Przeglad Gastroenterologiczny

Volumn 3, Issue 4, 2008, Pages 169-175

  Nowakowska Duława, Ewa ^a   Romańczyk, Tomasz ^a   Marek, Tomasz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Biliary stenting; Endoscopic retrograde cholangiopancreatography; Endoscopic sphincterotomy; Pancreatic stenting

Indexed keywords

ACUTE PANCREATITIS; BILE DUCT STONE; CHOLECYSTECTOMY; CHOLECYSTITIS; CHRONIC PANCREATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; META ANALYSIS; PALLIATIVE THERAPY; PANCREAS CANCER; PATIENT SAFETY; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STENT; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW;

EID: 64349097517     PISSN: 18955770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Martin DJ, Vernon DR, Toouli J. Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev 2006; 2: CD003327.
2. Rábago LR, Vicente C, Soler F i wsp. Two-stage treatment with preoperative endoscopic retrograde cholangiopancreatography (ERCP) compared with single-stage treatment with intraoperative ERCP for patients with symptomatic cholelithiasis with possible choledocholithiasis. Endoscopy 2006; 38: 779-86.
3. Morino M, Baracchi F, Miglietta C i wsp. Preoperative endoscopic sphincterotomy versus laparoendoscopic rendezvous in patients with gallbladder and bile duct stones. Ann Surg 2006; 244: 889-93.
4. Lella F, Bagnolo F, Rebuffat C i wsp. Use of the laparoscopic-endoscopic approach, the so-called "rendezvous" technique, in cholecystocholedocholithiasis: a valid method in cases with patient-related risk factors for post-ERCP pancreatitis. Surg Endosc 2006; 20: 419-23.
5. Cohen S, Bacon BR, Berlin JA i wsp. National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc 2002; 56: 803-9.
6. DiSario J, Chuttani R, Croffie J i wsp. Biliary and pancreatic lithotripsy devices. Gastrointest Endosc 2007; 65: 750-6.
7. McAlister VC, Davenport E, Renouf E. Cholecystectomy deferral in patients with endoscopic sphincterotomy. Cochrane Database Syst Rev 2007; 4: CD006233.
8. Vracko J, Markovic S, Wiechel KL. Conservative treatment versus endoscopic sphincterotomy in the initial management of acute cholecystitis in elderly patients at high surgical risk. Endoscopy 2006; 38: 773-8.
9. Toyota N, Takada T, Amano H i wsp. Endoscopic naso-gallbladder drainage in the treatment of acute cholecystitis: alleviates inflammation and fixes operator's aim during early laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg 2006; 13: 80-5.
10. Schlenker C, Trotter JF, Shah RJ i wsp. Endoscopic gallbladder stent placement for treatment of symptomatic cholelithiasis in patients with end-stage liver disease. Am J Gastroenterol 2006; 101: 278-83.
11. Forsmark CE, Baillie J; AGA Institute Clinical Practice and Economics Committee; AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology 2007; 132: 2022-44.
12. Mumtaz K, Hamid S, Jafri W. Endoscopic retrograde cholangiopancreaticography with or without stenting in patients with pancreaticobiliary malignancy, prior to surgery. Cochrane Database Syst Rev 2007; 3: CD006001.
13. Artifon EL, Sakai P, Cunha JE i wsp. Surgery or endoscopy for palliation of biliary obstruction due to metastatic pancreatic cancer. Am J Gastroenterol 2006; 101: 2031-7.
14. Moss AC, Morris E, Leyden J, MacMathuna P. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev 2007; 33: 213-21.
15. Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 2006; 63: 986-95.
16. Yoon WJ, Lee JK, Lee KH i wsp. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc 2006; 63: 996-1000.
17. Somogyi L, Chuttani R, Croffie J i wsp. Biliary and pancreatic stents. Gastrointest Endosc 2006; 63: 910-9.
18. Davids PH, Rauws EA, Tytgat GN, Huibregtse K. Postoperative bile leakage: endoscopic management. Gut 1992; 33: 1118-22.
19. Katsinelos P, Kountouras J, Paroutoglou G i wsp. A comparative study of 10-Fr vs. 7-Fr straight plastic stents in the treatment of postcholecystectomy bile leak. Surg Endosc 2008; 22: 101-6.
20. Laukkarinen J, Nordback I, Mikkonen J i wsp. A novel biodegradable biliary stent in the endoscopic treatment of cystic-duct leakage after cholecystectomy. Gastrointest Endosc 2007; 65: 1063-8.
21. Misra SP, Dwivedi M. Endoscopic management of persistent biliary leakage resulting from complete transection of the bile duct at cholecystectomy. Endoscopy 2006; 38: 598-603.
22. Costamagna G, Bulajic M, Tringali A i wsp. Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results. Endoscopy 2006; 38: 254-9.
23. Cahen DL, Gouma DJ, Nio Y i wsp. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med 2007; 356: 676-84.
24. Dumonceau JM, Costamagna G, Tringali A i wsp. Treatment for painful calcified chronic pancreatitis: extracorporeal shock wave lithotripsy versus endoscopic treatment: a randomised controlled trial. Gut 2007; 56: 545-52.
25. Andriulli A, Loperfido S, Napolitano G i wsp. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007; 102: 1781-8.
26. Cheng C, Sherman S, Watkins JL i wsp. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006; 101: 139-47.
27. Barrie M, Klein SD, Brown CA i wsp. Endoscopic retrograde cholangiopancreatography after a liquid fatty meal: effect on deep common bile duct cannulation time. Endoscopy 2006; 38: 241-8.
28. Kaffes AJ, Bourke MJ, Ding S i wsp. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis. Gastrointest Endosc 2006; 64: 351-7.
29. Tamas G, Tulassay Z, Papp J i wsp. Effect of somatostatin on the pancreatic-like biochemical changes due to endoscopic pancreatography: a preliminary report. Metabolism 1978; 27: 1333-6.
30. Milewski J, Rydzewska G, Degowska M i wsp. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. World J Gastroenterol 2006; 12: 3751-5.
31. Montaño Loza A, Rodríguez Lomelí X, García Correa JE i wsp. Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes. Rev Esp Enferm Dig 2007; 99: 330-6.
32. Sotoudehmanesh R, Khatibian M, Kolahdoozan S i wsp. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol 2007; 102: 978-83.
33. Thomopoulos KC, Pagoni NA, Vagenas KA i wsp. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc 2006; 64: 726-31.
34. Testoni PA, Mariani A, Masci E i wsp. Frequency of post-ERCP pancreatitis in a single tertiary referral center without ant with routine prophylaxis with gabexate: a six-year survey. Dig Liv Dis 2006; 38: 588-95.
35. Rudin D, Kiss A, Wetz RV, Sottile VM i wsp. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. J Gastroenterol Hepatol 2007; 22: 977-83.
36. Zheng M, Chen Y, Yang X i wsp. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterol 2007; 7: 6.
37. Andriulli A, Leandro G, Federici T i wsp. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007; 65: 624-32.
38. Testoni PA. Facts and fiction in the pharmacologic prevention of post-ERCP pancreatitis: a never-ending story. Gastrointest Endosc 2006; 64: 732-4.
39. Andriulli A, Forlano R, Napolitano G i wsp. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks. Digestion 2007; 75: 156-63.
40. Sofuni A, Maguchi H, Itoi T i wsp. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol 2007; 5: 1339-46.
41. Zhou PH, Yao LQ, Xu MD i wsp. Application of needle-knife in difficult biliary cannulation for endoscopic retrograde cholangiopancreatography. Hepatobiliary Pancreat Dis Int 2006; 5: 590-4.
42. Varadarajulu S, Wilcox CM. Randomized trial comparing needle-knife and pull-sphincterotome techniques for pancreatic sphincterotomy in high-risk patients. Gastrointest Endosc 2006; 64: 716-22.
43. Fisher L, Fisher A, Thomson A. Cardiopulmonary complications of ERCP in older patients. Gastrointest Endosc 2006; 63: 948-55.
44. Rastogi A, Campbell DR. ERCP in the elderly: how safe is it? (marathons, marathon ERCPs, and marathon ERCPs in the elderly). Gastrointest Endosc 2006; 63: 956-8.
45. Chutkan RK, Ahmad AS, Cohen J i wsp.; ERCP Core Curriculum prepared by the ASGE Training Committee. ERCP core curriculum. Gastrointest Endosc 2006; 63: 361-76.
46. Baron TH, Petersen BT, Mergener K i wsp. Quality indicators for endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 2006; 63 (4 Suppl): S29-34.